Cognitive reserve and lifestyle: moving towards preclinical Alzheimer’s disease

Cognitive reserve and lifestyle: moving towards preclinical Alzheimer’s disease

The large majority of neuroimaging studies in Alzheimer’s disease (AD) patients have supported the idea that lifestyle factors may protect against the clinical manifestations of AD rather than influence AD neuropathological processes (the cognitive reserve hypothesis). This evidence argues in favor...

Full description

Bibliographic Details
Main Authors:	Eider M Arenaza-Urquijo, Miranka eWirth, Gael eChételat
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-08-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Amyloid Cognitive Reserve Neuroimaging Neuroprotection Alzheimer’s disease Compensation
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnagi.2015.00134/full

Similar Items

Editorial: Measurable brain and cognitive reserve: The implication of neuroimaging biomarkers in the normal aging process
by: Chu-Chung Huang, et al.
Published: (2022-09-01)

Looking for a Treatment for the Early Stage of Alzheimer’s Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin
by: Roberta Facchinetti, et al.
Published: (2020-05-01)

Effects of Cognitive Reserve in Alzheimer’s Disease and Cognitively Unimpaired Individuals
by: Dong Hyuk Lee, et al.
Published: (2022-02-01)

Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2
by: Zerrin Yildirim, et al.
Published: (2023-02-01)

Translational research on reserve against neurodegenerative disease: consensus report of the International Conference on Cognitive Reserve in the Dementias and the Alzheimer’s Association Reserve, Resilience and Protective Factors Professional Interest Area working groups
by: Robert Perneczky, et al.
Published: (2019-02-01)

Inflamación relacionada con angiopatía amiloide: características clínicas y respuesta al tratamiento en una serie de casos
by: P. Martín-Jiménez, et al.
Published: (2023-10-01)

New prospects on cerebellar reserve: Remarks on neuroprotective effects of experience in animals and humans
by: Francesca Gelfo, et al.
Published: (2023-01-01)

Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications
by: Luiz Kobuti Ferreira, et al.
Published: (2011-01-01)

Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent Insights
by: Chiara Villa, et al.
Published: (2020-07-01)

Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review
by: Tien-Wei Yu, et al.
Published: (2021-07-01)

Why could meditation practice help promote mental health and well-being in aging?
by: Gaël Chételat, et al.
Published: (2018-06-01)

NREM sleep as a novel protective cognitive reserve factor in the face of Alzheimer's disease pathology
by: Zsófia Zavecz, et al.
Published: (2023-05-01)

Hemispheric dissociations in regions supporting auditory sentence comprehension in older adults
by: Yune Sang Lee, et al.
Published: (2022-01-01)

Deciphering the Potential Neuroprotective Effects of Luteolin against Aβ<sub>1</sub>–<sub>42</sub>-Induced Alzheimer’s Disease
by: Sareer Ahmad, et al.
Published: (2021-09-01)

Residual reserve index modifies the effect of amyloid pathology on fluorodeoxyglucose metabolism: Implications for efficiency and capacity in cognitive reserve
by: Cathryn McKenzie, et al.
Published: (2022-08-01)

Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes
by: Marta Valenza, et al.
Published: (2021-04-01)

Imaging spectrum of amyloid-related imaging abnormalities associated with aducanumab immunotherapy
by: Houman Sotoudeh, et al.
Published: (2024-01-01)

Azilsartan ameliorates aluminium chloride induced Alzheimer’s disease like pathology
by: Mishra Sunita, et al.
Published: (2023-09-01)

Gait in Cerebral Amyloid Angiopathy
by: Breni Sharma, et al.
Published: (2022-10-01)

Purpose in life promotes resilience to age-related brain burden in middle-aged adults
by: Kilian Abellaneda-Pérez, et al.
Published: (2023-03-01)

Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer’s Disease Proteinopathy: Possible Therapeutic Role of Curcumin
by: Ryszard Pluta, et al.
Published: (2022-01-01)

Unconjugated PLGA nanoparticles attenuate temperature-dependent β-amyloid aggregation and protect neurons against toxicity: implications for Alzheimer’s disease pathology
by: Pallabi Sil Paul, et al.
Published: (2022-02-01)

Private goals and monetary policy: inflation and resignations from the Federal Reserve Board
by: J.B CRIHFIELD, et al.
Published: (2013-10-01)

Exploring the links among peripheral immunity, biomarkers, cognition, and neuroimaging in Alzheimer's disease
by: Jie‐Qiong Li, et al.
Published: (2023-10-01)

Understanding the Pathophysiology of Cerebral Amyloid Angiopathy
by: Laura Gatti, et al.
Published: (2020-05-01)

A Case of Cerebral Amyloid Angiopathy-Related Inflammation With the Rare Apolipoprotein ε2/ε2 Genotype
by: Yin-Yan Xu, et al.
Published: (2019-05-01)

Influencing Factors and Measurement of “Willingness to Accept” Living with Alligators in a Nature Reserve: A Case Study in National Chinese Alligator Nature Reserve, China
by: Yefei Liu, et al.
Published: (2022-10-01)

Primary School Education May Be Sufficient to Moderate a Memory-Hippocampal Relationship
by: Elisa de Paula França Resende, et al.
Published: (2018-11-01)

Research on the efficiency optimization of food reserve under the complementary reserve mode of government and enterprise in China
by: Qijun Jiang, et al.
Published: (2024-03-01)

Progress on the different methods of reserves calculation in the whole life cycle of gas reservoir development
by: Yunsheng Wei, et al.
Published: (2021-02-01)

Cycloastragenol, a Triterpenoid Saponin, Regulates Oxidative Stress, Neurotrophic Dysfunctions, Neuroinflammation and Apoptotic Cell Death in Neurodegenerative Conditions
by: Muhammad Ikram, et al.
Published: (2021-10-01)

Iteressi privati e politica monetaria: inflazione e dimissioni del Federal Reserve Board
by: J.B. CRIHFIELD, et al.
Published: (2013-10-01)

Alzheimer’s Disease and Green Tea: Epigallocatechin-3-Gallate as a Modulator of Inflammation and Oxidative Stress
by: Víctor Valverde-Salazar, et al.
Published: (2023-07-01)

Comparing Pathological Risk Factors for Dementia between Cognitively Normal Japanese and Americans
by: Chendi Cui, et al.
Published: (2021-09-01)

Holothuria scabra extracts confer neuroprotective effect in C. elegans model of Alzheimer's disease by attenuating amyloid-β aggregation and toxicity
by: Warannida Kleawyothatis, et al.
Published: (2023-01-01)

Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APP<sub>swe</sub> Alzheimer’s Disease Mouse Model
by: Marta Zamarbide, et al.
Published: (2022-03-01)

A new look on reserves prediction of unconventional shale gas plays: moving from static parameters to dynamic, operation-based reserves’ calculation
by: Fatimah Larasati Putri Pratami, et al.
Published: (2019-03-01)

Fractal motor activity regulation and sex differences in preclinical Alzheimer's disease pathology
by: Lei Gao, et al.
Published: (2021-01-01)

Improved connectivity and cognition due to cognitive stimulation in Alzheimer’s disease
by: Qumars Behfar, et al.
Published: (2023-08-01)

Brain iron content in cerebral amyloid angiopathy using quantitative susceptibility mapping
by: Breni Sharma, et al.
Published: (2023-04-01)